Dr. Dimple Doshi (MBBS, MD, DGO)
Lady Gynecologist & Laparoscopic Surgeon
27+ years’ experience
20,000+ surgeries completed
Persistent bloating, pelvic pain, urinary frequency, or an ovarian cyst on sonography can feel worrying, especially after 40 or after menopause.
Many women confuse ovarian cancer warning signs with gas, acidity, IBS, urinary infection, or menopause-related changes.
In my clinical experience, early evaluation of persistent symptoms and suspicious ovarian masses can help women receive the right care at the right time.
This guide explains ovarian cancer symptoms, diagnosis, CA-125, suspicious ovarian cysts, safe cyst removal, and preventive fallopian tube removal during hysterectomy.
Ovarian cancer is a cancer that may start in the ovary, fallopian tube, or nearby peritoneal lining and needs early evaluation.
Ovarian cancer is not one single disease.
It may include cancer arising from:
Many cancers previously called “ovarian cancer” are now understood to begin in the fallopian tube, especially near the fimbrial end.
Ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer are often grouped together because they behave and are treated in similar ways.
Dr. Dimple Doshi’s Tip:
Do not wait for severe symptoms. If bloating, pelvic pain, urinary symptoms, or abdominal heaviness are new and persistent, evaluation is safer than guessing.
Ovarian cancer is often detected late because early symptoms are vague, mild, digestive-like, or mistaken for common problems.
Many women initially ignore symptoms because they feel like:
This is why ovarian cancer is often called a silent or whispering disease.
But it is not completely silent.
The body often gives signals.
The problem is that the signals may look ordinary.
Dr. Dimple Doshi’s Tip:
Persistent symptoms matter more than dramatic symptoms. Repeated bloating or pelvic discomfort deserves attention, especially after menopause.
Common warning symptoms include persistent bloating, pelvic pain, early fullness after meals, urinary frequency, and abdominal swelling.
Symptoms may include:
NICE recommends ultrasound of the abdomen and pelvis as the first imaging test in secondary care when ovarian cancer is suspected. If ultrasound, CA-125, and clinical condition suggest ovarian cancer, CT scan is recommended to assess disease extent.
Symptoms that are new, persistent, progressive, or frequent—especially after 40 or menopause—should be evaluated by a gynecologist.
Please do not ignore:
If bloating, pelvic pain, urinary symptoms, or early fullness are:
then evaluation is safer than waiting.
Persistent bloating or pelvic pain should not be ignored.
Most causes may be simple, but a careful gynecological evaluation can rule out serious conditions early.
Consult Dr. Dimple Doshi at Vardaan Hospital, Goregaon West, Mumbai.
Risk is higher with increasing age, menopause, family history, BRCA mutations, Lynch syndrome, endometriosis, and some reproductive factors.
Important risk factors include:
Women with strong family history or genetic risk may need genetic counselling and specialist guidance.
Dr. Dimple Doshi’s Tip:
If your mother, sister, or daughter had ovarian cancer, or there is strong breast cancer history in the family, please discuss genetic-risk counselling.
Most ovarian cysts are benign, but complex, solid, persistent, large, or postmenopausal ovarian cysts need careful cancer-risk evaluation.
Most ovarian cysts in reproductive-age women are benign, such as:
But some cysts need caution.
A cyst is not called cancer only by appearance.
But a suspicious ovarian mass should be evaluated properly before planning treatment.
Ovarian cancer diagnosis usually involves clinical examination, ultrasound, tumor markers, CT scan, and specialist oncology referral when suspicious.
Evaluation may include:
NICE recommends ultrasound as the first imaging test in secondary care and CT scan when ultrasound, CA-125, and clinical status suggest ovarian cancer.
Dr. Dimple Doshi’s Tip:
Diagnosis should not depend on one test alone. Symptoms, age, ultrasound findings, tumor markers, and clinical examination must be interpreted together.
Tests are selected according to age, symptoms, ultrasound findings, menopausal status, and whether the ovarian mass looks simple or suspicious.
Test | Why It Is Done |
Pelvic examination | To assess pelvic mass, tenderness, mobility |
Transvaginal ultrasound | First-line imaging for ovarian cyst or mass |
CA-125 | Helpful marker, especially after menopause |
HE4 / ROMA | May help in selected adnexal masses |
CEA | Useful when mucinous tumor or GI source is considered |
CA 19-9 | May rise in mucinous ovarian tumors or GI conditions |
CT scan | To assess spread if cancer is suspected |
MRI pelvis | Useful when ultrasound findings are unclear |
Histopathology | Final diagnosis after surgical tissue evaluation |
Not every patient needs every test.
The test plan depends on symptoms, scan findings, menopausal status, and cancer-risk assessment.
CA-125 is a helpful tumor marker, but it is not a perfect ovarian cancer test and must be interpreted with symptoms and imaging.
CA-125 may rise in ovarian cancer.
But it can also rise in benign conditions like:
CA-125 may also be normal in some early ovarian cancers.
Cancer Research UK notes that CA-125 is not completely reliable because some ovarian cancers may have normal CA-125, and some non-cancerous conditions can also raise it.
A normal CA-125 does not always mean no cancer.
A high CA-125 does not always mean cancer.
It is one part of the complete evaluation.
Dr. Dimple Doshi’s Tip:
Please do not panic after a raised CA-125 report. It needs to be interpreted with ultrasound, symptoms, age, and clinical findings.
Routine ovarian cancer screening is not recommended for average-risk women because current tests do not reliably detect early cancer in all women.
For average-risk women, routine screening with CA-125 and ultrasound has not been proven reliable enough to reduce ovarian cancer deaths and can lead to false alarms.
However, women with strong family history or genetic risk need individualized counselling.
Dr. Dimple Doshi’s Tip:
Average-risk screening and high-risk surveillance are different. If your family history is strong, do not rely on routine check-ups alone — ask about genetic counselling.
A suspicious ovarian mass should be handled gently, removed in a protective bag when appropriate, and managed without rupture or spillage.
When an ovarian cyst or mass looks suspicious or indeterminate, surgical planning becomes very important.
The aim is to:
During laparoscopic surgery, the ovarian cyst or mass can be placed inside a sterile specimen retrieval bag, also called an:
The mass is then removed in a protected manner so that cyst contents do not spill inside the abdomen.
This is especially important when the cyst is:
Think of it like sealing the cyst inside a medical pouch before bringing it out.
This helps reduce the chance of cyst contents spreading to nearby tissues.
No-spill removal helps protect surrounding tissues and is especially important when the nature of the ovarian mass is uncertain.
In ovarian cyst surgery, spillage may cause different problems depending on cyst type.
For example:
If the ovarian mass has a high suspicion of cancer before surgery, the safest pathway is usually gynecologic oncology referral for proper staging surgery.
At Vardaan Hospital, when a mass is suspicious, the focus is on:
Dr. Dimple Doshi’s Tip:
When the cyst is complex or indeterminate, surgical handling matters. The aim is to remove it safely, avoid rupture, and send tissue for proper diagnosis.
Some indeterminate or selected suspicious-looking masses may be removed laparoscopically, but high-risk cancer cases need oncology-led planning.
Laparoscopy may be suitable when:
Laparoscopy may not be the best option when there is:
In such cases, referral to a gynecologic oncologist is safer.
3D laparoscopy improves depth perception, helping the surgeon identify tissue planes and remove suitable ovarian cysts more precisely.
At Vardaan Hospital, Goregaon West, Mumbai, selected ovarian cysts and benign gynecologic surgeries may be performed with the Karl Storz Rubina 4K 3D laparoscopy system.
3D laparoscopic vision may help in:
When a suspicious or complex ovarian cyst is suitable for laparoscopy, safe removal in a bag without spillage is an important surgical principle.
Yes. Removing both fallopian tubes during hysterectomy may reduce future risk of epithelial ovarian cancer, especially high-grade serous cancer.
This is called:
During a laparoscopic hysterectomy, if the ovaries are healthy and can be safely preserved, both fallopian tubes may be removed along with the uterus.
This is done because many high-grade serous ovarian-type cancers are now believed to start from the fimbrial end of the fallopian tube.
ACOG states that opportunistic salpingectomy may decrease ovarian cancer risk when performed during pelvic surgery for benign disease, but it does not eliminate the risk completely.
ACOG also notes that salpingectomy at hysterectomy appears safe and does not increase complications such as blood transfusion, readmission, postoperative complications, infection, or fever compared with hysterectomy alone.
The tubes are removed because many serious ovarian-type cancers may begin in the fallopian tube, while preserving ovaries helps maintain hormones.
Removing fallopian tubes may help with:
Preserving ovaries may help protect:
This is why many women undergoing hysterectomy for benign disease may be counselled about fallopian tube removal with ovarian preservation.
Dr. Dimple Doshi’s Tip:
For many average-risk women, tube removal with ovary preservation during hysterectomy can be a balanced preventive discussion — but it must be individualized.
No. Salpingectomy reduces ovarian cancer risk, but it cannot make the risk zero because cancer may still arise from the ovary or peritoneum.
Correct message:
The Society of Gynecologic Oncology states that for women at population risk, salpingectomy should be considered after completion of childbearing at the time of hysterectomy or other pelvic surgery.
Yes, when technically feasible, salpingectomy during hysterectomy is generally considered safe and does not appear to increase major surgical complications.
At Vardaan Hospital, Goregaon West, Mumbai, salpingectomy can often be performed during 3D laparoscopic hysterectomy using the Karl Storz Rubina 4K 3D laparoscopy system.
The 3D view helps the surgeon identify:
This helps perform tube removal precisely while preserving healthy ovaries when appropriate.
Women undergoing hysterectomy for benign disease may consider salpingectomy if they have completed family and tube removal is safely possible.
It may be discussed during hysterectomy for:
It is especially relevant when:
Women with BRCA mutation, strong family history, or suspected ovarian cancer need individualized oncologic counselling, not routine salpingectomy alone.
Opportunistic salpingectomy is mainly for average-risk women undergoing pelvic surgery for another benign indication.
Women may need genetic counselling or gynecologic oncology referral if they have:
For high-risk women, salpingectomy alone may not be enough.
Risk-reducing salpingo-oophorectomy may be advised after specialist counselling depending on age, mutation status, fertility plans, and menopause considerations.
Treatment usually involves surgery, chemotherapy, and sometimes targeted therapy, depending on stage, type, fitness, and oncology assessment.
Treatment depends on:
Common treatment options include:
When ovarian cancer is strongly suspected, management should be guided by a gynecologic oncology team.
A gynecologist helps identify warning symptoms, evaluate ovarian masses, order appropriate tests, and refer early when cancer is suspected.
At Vardaan Hospital, the focus is on:
When ovarian cancer is suspected, the safest pathway is specialist gynecologic oncology care for staging and definitive cancer surgery.
A general gynecologist’s role is extremely important in:
Dr. Dimple Doshi’s Tip:
My role is to identify warning signs early, evaluate ovarian cysts properly, and guide patients to the safest treatment pathway — including oncology referral when needed.
Ovarian cancer cannot always be prevented, but risk can be reduced in selected women through awareness, genetic counselling, and preventive surgery.
Possible risk-reduction strategies may include:
Prevention is not only about avoiding disease.
It is also about detecting risk early and taking the right step at the right time.
You should book a gynecology consultation if bloating, pelvic pain, urinary frequency, early fullness, or an ovarian cyst persists.
Book an appointment if you have:
Do not wait for symptoms to become severe.
Persistent bloating, pelvic pain, or a suspicious ovarian mass deserves careful gynecological evaluation.
Book a consultation with Dr. Dimple Doshi at Vardaan Hospital, Goregaon West, Mumbai.
Dr. Dimple Doshi provides ethical, timely, and careful evaluation of ovarian cysts, pelvic pain, ovarian cancer warning symptoms, and preventive options.
Patients choose Dr. Dimple Doshi for:
At Vardaan Hospital, Goregaon West, Mumbai, the priority is:
During laparoscopic surgery for selected ovarian cysts or indeterminate ovarian masses, careful tissue handling and protected specimen retrieval are important.
When appropriate, the cyst or mass is placed inside a sterile retrieval bag and removed in a controlled way to avoid spillage into the abdomen.
For hysterectomy patients, Dr. Dimple Doshi also discusses fallopian tube removal with ovarian preservation whenever suitable.
This may help reduce the future risk of certain ovarian-type cancers while preserving natural ovarian hormone function.
At Vardaan Hospital, Goregaon West, Mumbai, these decisions are made after:
suitability assessment for advanced Karl Storz Rubina 4K 3D laparoscopic vision
Ans. The first signs may be persistent bloating, pelvic pain, early fullness after eating, urinary frequency, and abdominal heaviness.
These symptoms are often mistaken for gas, acidity, UTI, or menopause.
If symptoms are new and persistent, evaluation is important.
Ans. No. Most ovarian cysts are benign, especially in reproductive-age women.
But complex or postmenopausal cysts need careful evaluation.
A simple cyst and a suspicious ovarian mass are not the same. Ultrasound features, age, symptoms, and tumor markers guide risk.
Ans. No. CA-125 can support suspicion, but it cannot confirm ovarian cancer alone.
Diagnosis needs imaging, clinical assessment, and histopathology.
CA-125 may be raised in benign conditions and may be normal in some early cancers.
Ans. It means the cyst or mass is removed in a protective retrieval bag so that its contents do not leak inside the abdomen.
This is especially important for dermoid, mucinous, complex, endometriotic, or indeterminate ovarian cysts.
Ans. Some selected masses can be removed laparoscopically, but high-risk cancer cases need gynecologic oncology planning.
Suitability depends on imaging, tumor markers, age, menopausal status, ascites, spread, and overall cancer suspicion.
Ans. It can reduce the risk of certain epithelial ovarian-type cancers, but it does not completely prevent ovarian cancer.
Some cancers may still arise from the ovary or peritoneal lining.
Ans. No. Removing only the fallopian tubes does not cause menopause because the ovaries are preserved.
Menopause occurs when ovarian hormone function declines naturally or when both ovaries are removed.
Ans. It depends on age, risk, family history, and menopause status.
For many average-risk premenopausal women, tube removal with ovarian preservation is a balanced option.
For women with BRCA mutation or strong hereditary risk, specialist counselling is essential.
Ovarian cancer can be difficult to detect early because its symptoms often look like common digestive, urinary, or menopause-related problems.
Persistent bloating, pelvic pain, early fullness, urinary frequency, postmenopausal ovarian cysts, or complex ovarian masses should not be ignored.
In my clinical experience, the safest approach is early evaluation, correct imaging, careful interpretation of tumor markers, and timely referral when cancer suspicion is high.
At Vardaan Hospital, Goregaon West, Mumbai, Dr. Dimple Doshi provides ethical evaluation of ovarian cysts, pelvic pain, suspicious ovarian masses, ovarian cancer warning symptoms, and preventive surgical options. When suitable, selected ovarian cysts can be removed carefully in a protective retrieval bag to avoid spillage, and women undergoing hysterectomy may be counselled about fallopian tube removal with ovarian preservation.
Persistent bloating, pelvic pain, or suspicious ovarian cyst?
Do not delay evaluation.
Book your consultation with Dr. Dimple Doshi at Vardaan Hospital, Goregaon West, Mumbai.
